Home › Funds › RTW INVESTMENTS, LP › TSHA
RTW INVESTMENTS, LP position in TSHA
TAYSHA GENE THERAPIES INC · Health Care
RTW INVESTMENTS, LP reported holding 13,560,258 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q3 2026 13F filing — a position valued at US$66.0M, representing 0.67% of its reported portfolio and ranking #42 among its reported holdings. RTW INVESTMENTS, LP has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's TSHA position evolved
RTW INVESTMENTS, LP first disclosed a stake in TSHA in Q3 2023 at 16,893,185 shares (US$53.4M). The position peaked in Q2 2026 at 13,560,258 shares, worth US$92.3M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 13,560,258 shares valued at US$66.0M. Notable position changes include a 42% trim in Q4 2024 (shares fell 20% over the following quarter), a 117% increase in Q1 2025 (shares rose 66% over the following quarter), a 33% increase in Q2 2025 (shares rose 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 16.89M | $53.38M | New |
| Q4 2023 | 16.89M | $29.90M | Hold |
| Q1 2024 | 18.59M | $53.36M | Add |
| Q2 2024 | 18.80M | $42.11M | Add |
| Q3 2024 | 14.95M | $30.04M | Reduce |
| Q4 2024 | 8.67M | $15.00M | Reduce |
| Q1 2025 | 18.79M | $26.12M | Add |
| Q2 2025 | 25.02M | $57.80M | Add |
| Q3 2025 | 24.35M | $79.64M | Reduce |
| Q4 2025 | 16.40M | $90.19M | Reduce |
| Q1 2026 | 13.68M | $61.15M | Reduce |
| Q2 2026 | 13.56M | $92.35M | Reduce |
| Q3 2026 | 13.56M | $66.04M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TSHA and 13F data
TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 47 other funds we track also report a position in TSHA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M), Avoro Capital Advisors LLC (US$116.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TSHA
- RA CAPITAL MANAGEMENT, L.P. 23.56M sh · $160.41M · Q2 2026
- Vestal Point Capital, LP 19.41M sh · $132.22M · Q2 2026
- Avoro Capital Advisors LLC 23.89M sh · $116.34M · Q3 2026
- Octagon Capital Advisors LP 9.69M sh · $66.01M · Q2 2026
- Siren, L.L.C. 9.85M sh · $47.95M · Q3 2026
- MPM BioImpact LLC 4.50M sh · $30.64M · Q2 2026
- BAKER BROS. ADVISORS LP 4.00M sh · $27.27M · Q2 2026
- Casdin Capital 3.25M sh · $22.13M · Q2 2026
- ADAR1 Capital Management, LLC 3.06M sh · $14.90M · Q3 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 1.50M sh · $10.21M · Q2 2026
- Seven Fleet Capital Management LP 1.50M sh · $9.94M · Q2 2026
- Palo Alto Investors LP 1.39M sh · $9.48M · Q2 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held TSHA?
RTW INVESTMENTS, LP has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RTW INVESTMENTS, LP's current position in TSHA?
As of Q3 2026, RTW INVESTMENTS, LP holds 13.56M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $66.04M, representing 0.67% of its reported portfolio and ranking #42.
Has RTW INVESTMENTS, LP been buying or selling TSHA?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in TSHA. The position peaked in Q2 2026 at 13.56M shares.
Which other funds hold TSHA?
Other major institutional holders of TSHA include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Avoro Capital Advisors LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.